One Less EU Rule to be Followed - but Brussels Gets Few Plaudits
A European bid to impose additional limits on research involving human embryos has been defeated.
WIRB-Copernicus Group Launches WCG Oncology
The WIRB-Copernicus Group announced today the formation of a new cancer-focused institutional review board, WCG Oncology
Europe's Drug Regulator Makes a U-turn on Data Transparency
Redacted policy on sharing drug trial data in Europe.
Debate Grows Over EMA's Decision on Data Transparency
If the EMA also stops releasing data on old trials, everybody will be kept even more in the dark, according to an editorial posted by bmj.com on May 28.
Celerion Collaborates with South Korea to Strengthen Early Phase Clinical Research
Celerion and the Korean Drug Development Fund announced a formal collaboration
Q&A With Jean Burns: Insights from a Study Volunteer
Jean Burns shared experiences with me that offer important insights for government and industry funded clinical research sponsors to consider as they look to improve their partnership with study volunteers.
Celerion and Korean Drug Development Fund Form Collaboration to Strengthen Early Phase Clinical Research in South Korea
INC Research Becomes Global Impact Partner with Society for Clinical Research Sites
INC Research announced a two-year partnership with the Society for Clinical Research Sites.
How We Fall into Metrics Malpractice
Effective clinical trial management depends on accurate and unbiased performance measurement.
INC Research Announces Partnership with Society for Clinical Research
Partnership reinforces sites' pivotal role in clinical development, demonstrates Company's on-going commitment to fostering strong site
Overcoming Clinical Challenges in BRIC Markets - Russia
Thomson Reuters Cortellis Competitive Intelligence
Investigator Databank Expands Members and Launches Website
Novartis, Janssen, Merck (MSD outside the United States and Canada), Lilly, and Pfizer have joined with DrugDev in hosting a repository of specific investigator information as part of the Investigator Databank.
3 Ways CTMS Helps Manage Adaptive Trials
While adaptive trial designs have been slow to gain traction, there a many benefits to adopting this trial model.
PCI to Host Global Clinical Trial Services Seminar June 18, 2014 in Oxford, England
PCI will be hosting the latest in their Global Clinical Trial Services Seminar Series in Oxford, England on June 18, 2014.
PRA Completes 20th First in Human Biologics Trial
PRA announced it has completed its 20th first in human trial with biologics.
Highlights from the NewYorkBIO Conference: FDA Commissioner Hamburg Speaks
Investments, acquisitions in biotechnology, valuation, and regulatory innovation were main themes at the 2014 NewYorkBIO Conference.
Clinverse, Inc. Announces Strategic Partnership with eClinical Insights
Clinverse, Inc. and eClinical Insights announced today they have formed a strategic partnership.
Second Edition of The Gift of Participation Available: A Q&A with the Author
Kenneth Getz spoke to Applied Clinical Trials about his book, as well as the changes in clinical trials since the first edition.
Clinverse, eClinical Insights in Strategic Partnership
Clinverse and eClinical Insights announced a strategic partnership.
Business and People May 2014
FDA Beats PMDA and EMA on Oncology Approvals
FDA hands down beats other regulatory authorities in approving oncology drugs.
Major Skills Shortages Loom in Singapore
Future growth could be impacted by a marked skills shortage, according to a survey from Berkley Group.
Overcoming Clinical Challenges in BRIC Markets - Brazil
Technology Coalition Announces Integrated IT Platform
ACRES has unveiled a scheme to create an integrated information-management platform designed to support clinical research worldwide.
Start Your Search Right: Know the Decisions You'll Need to Make When You Search for a CTMS
Finding the right CTMS is a long, difficult process.
Is EMA Back-Tracking on Open Data Promises?
Concerns are emerging among researchers that the European Medicines Agency is not following through with its pledge to open clinical trials data to public scrutiny.
Medidata and TransCelerate BioPharma Join on Risk-Based Monitoring Methodology
Medidata announced that it is partnering with TransCelerate BioPharma
EMA: Damned if it Does, Damned if it Doesn't
EMA's crowning achievement in transparency?proactive release of clinical trials data?is only weeks from finalization.
Skills Shortages Could Scupper Singapore's Growth Prospects
As confidence returns to job seekers, high levels of staff movement could impact on organizations' growth.
Medidata and TransCelerate BioPharma Inc. Announce Joint Initiative
Collaboration to explore key components of recommended Risk-Based Monitoring methodology